“Pattern recognition is key,” emphasized Prem S. Subramanian, MD, PhD, as he discussed the challenges of distinguishing ...

Can you share some highlights from the BETTER study with us? Marion Munk, MD, PhD: I'm very excited about this project. We ...

Canadian medical device company MacuMira Medical Devices recently introduced the first Health Canada-approved treatment to ...

Smith highlights advances in interventional glaucoma, including first-line SLT, emerging surgical options, and co-management strategies, during the Ophthalmology Times and Optometry Times EyeCon 2025 ...

The recipients of this year’s Visionary in Eye Care Resident Recognition Awards were revealed at the Ophthalmology Times and Optometry Times EyeCon® 2025 conference, held September 26 and 27 at the ...

STAAR and Broadwood Partners have recently pleaded their case in the proposed merger between STAAR and Alcon, issuing ...

A study of the effects of repetitive impacts to the head during one season of football found that the smooth pursuit velocity ...

Considering rapid increases in myopia, authors conducted a longitudinal cohort study of twins and their parents with the goal ...

Daniela Bacherini, MD, PhD, FEBO, from the University of Florence presented at the EURETINA 2025 meeting, focusing on ultra ...

Their answers reflect the diversity of challenges facing ophthalmologists today, from the most common causes of vision loss ...

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals' Abbreviated New Drug Application (ANDA) for ...

For anyone unfamiliar with the Ramin Tadayoni Award, can you explain this honor? Anat Loewenstein, MD: The Ramin Tadayoni Award is one of the most exciting endeavors of the EURETINA board, along with ...